Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read moreLatest press releases
- GSK joins forces with the University of California to advance genomic research and improve drug discovery
- GSK announces data on anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma to be presented at European Hematology Association (EHA) Congress
- Nucala (mepolizumab) gains FDA approval for two new self-administration options
- Nucala (mepolizumab) receives positive CHMP opinion for new self-administration options
Tweets from GSK
-
GSK @GSK
Strong medicine targets for #cancer are rare. We’re in the race to explore BCMA to fight #multiplemyeloma for patients. Read more from @NatRevDrugDisc: gsk.to/31E4zoV
about 20 hours ago
-
GSK @GSK
“Sometimes things in science do go wrong. And when things go wrong, it’s important to keep in mind the greater goal - which is to improve patients’ lives. And the stronger that goal, the wider my smile.” #MondayMotivation from Radu, one of our functional genomics investigators.
about 2 days ago -
GSK @GSK
#ICYMI last week we announced a five-year collaboration with @UCBerkeley and @UCSF to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR). Find out how we plan to accelerate the development of new medicines
about 2 days ago
